Building strategic partnerships to advance clinical excellence - our recent collaboration with Sharehereon Health has opened doors to high-quality refractory cancer care at Parkway Shanghai Hospital.
On 1 November, Parkway Shanghai Hospital partnered Professor Ding Gang, Founder of Sharehereon Health, to launch the Parkway Shanghai Hospital Oncology Center and Parkway International Refractory Oncology Consultation Center. This strategic collaboration unifies the expertise and resources of both healthcare organisations to deliver better oncology diagnosis and treatment for cancer patients.
“This strategic partnership is a harbinger of more great things to come. Refractory cancer, which is the cancer resistant to standard treatment, is a high potential segment in the private healthcare space and there’s great promise in it cementing our domain expertise in oncology,” shared Dr Prem Kumar Nair, Group CEO of IHH Healthcare, during his opening address.
Buoyed by this new development, IHH China will continue to innovate clinical practices, foster multidisciplinary cooperation and prioritise holistic patient care, to bring hope and improved outcomes to more cancer patients in Shanghai.
Related Stories
IHH Healthcare Strengthens India Presence with Integrated Platform and Innovation Push
IHH Healthcare is accelerating its expansion in India, as rising healthcare demand drives the Group to scale its operations through integration, capacity growth and innovation-led initiatives.
IHH Healthcare calls for urgent shift from climate awareness to action at Sustainability Week Asia
At the 6th annual Economist Impact Sustainability Week Asia, IHH Healthcare’s Group Chief Sustainability Officer Yasemin Tecmen Stubbe underscored the growing urgency for organisations to embed climate resilience into day-to-day operations, rather than treating it as a future concern.
Parkway Shanghai Hospital Inaugurates Pan Vascular Centre
The new multidisciplinary hub integrates six specialties to deliver full-cycle care for vascular diseases, reinforcing healthcare innovation in China.
Fortis Healthcare Hosts 1st Annual Neuro-conclave Mumbai 2026
Fortis Healthcare marked the successful conclusion of the 1st Annual Neuro-conclave Mumbai 2026, held on 21 and 22 March, showcasing the strength and integration of its neuroscience team.
Enhancing Patient Journeys at Pantai Hospital Melaka
